Gland Chemicals Private Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is BORTEZOMIB, with a corresponding US DMF Number 26440.
Remarkably, this DMF maintains an Active status since its submission on October 31, 2012, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of May 06, 2013, and payment made on February 20, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II